The 118th Annual Meeting of the Swiss Ophthalmological Society (SOG 2025) will take place from 27–29 August 2025 at the Congress Center Basel. This major national congress brings together leading experts from Switzerland and abroad to discuss advances in ophthalmic research, clinical practice, and innovation. The ELZA Institute is proud to contribute with high-impact scientific presentations in this year’s program.
Highlighting New Data on High-Fluence CXL at SOG
On Thursday, 28 August 2025, ELZA researchers will present important five-year data on high-fluence accelerated epi-off CXL for advanced progressive keratoconus.
SOG Oral Free Paper Presentation
A High-Fluence Accelerated Epi-Off CXL Protocol for Advanced Progressive Keratoconus: A Prospective, Interventional Cohort Study
Authors: M.E. Aydemir, M. Hillen, S. Awwad, J. Assaf, L. Kollros, N.L. Hafezi, L. Paulasto, M.L. Depczynska, J. Khurramov, E.A. Torres-Netto, F. Hafezi.
ePoster on CXL Complications
Also on the program is an ePoster addressing rare complications after cross-linking:
Central Toxic Keratopathy After Epi-Off CXL
Authors: M.E. Aydemir, E.A. Torres-Netto, M. Hillen, F. Blaser, Z. Gatzioufas, S. Awwad, F. Hafezi.
Chairing and Industry Contributions
Beyond research presentations, ELZA faculty will also play prominent roles in chairing and moderating sessions:
Prof. Farhad Hafezi will serve as chair in the ESCRS Academy session, reflecting his international leadership in refractive and corneal surgery.
Dr. Emilio Torres-Netto will deliver an industry booth talk on Friday, 29 August, sharing ELZA’s surgical expertise with clinicians and industry partners.
ELZA’s Presence at SOG 2025
With oral free papers, ePosters, chairing roles, and booth talks, ELZA’s strong presence at SOG 2025 demonstrates its ongoing mission to combine rigorous clinical research with patient-oriented innovation.
The congress offers a unique opportunity to connect with colleagues, discuss scientific advances, and explore how new protocols such as personalised fluence cross-linking can redefine treatment standards for keratoconus and other corneal ectatic diseases.
